Triple combinations in chronic obstructive pulmonary disease–is three better than two?

M Cazzola, MG Matera - Expert Opinion on Pharmacotherapy, 2014 - Taylor & Francis
A growing body of evidence suggests that triple therapy with an antimuscarinic agent, a long-
acting β2-agonist, and an inhaled corticosteroid is efficacious in patients with more severe …
被引用次数：32 相关文章

Triple combinations in chronic obstructive pulmonary disease-is three better than two?

M Cazzola, MG Matera - Expert opinion on …, 2014 - pubmed.ncbi.nlm.nih.gov
A growing body of evidence suggests that triple therapy with an antimuscarinic agent, a long-
acting β2-agonist, and an inhaled corticosteroid is efficacious in patients with more severe …

[引用][C] Triple combinations in chronic obstructive pulmonary disease-is three better than two?

M Cazzola, MG Matera - EXPERT OPINION ON …, 2014 - iris.unicampania.it
Triple combinations in chronic obstructive pulmonary disease - is three better than two? IRIS IRIS
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English …

[引用][C] Triple combinations in chronic obstructive pulmonary disease–is three better than two?

M Cazzola, M Matera - EXPERT OPINION ON …, 2014 - art.torvergata.it
Triple combinations in chronic obstructive pulmonary disease – is three better than two?
IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie Settore …

Triple combinations in chronic obstructive pulmonary disease-is three better than two?

M Cazzola, MG Matera - Expert Opinion on Pharmacotherapy, 2014 - europepmc.org
A growing body of evidence suggests that triple therapy with an antimuscarinic agent, a long-
acting β2-agonist, and an inhaled corticosteroid is efficacious in patients with more severe …
[PDF] researchgate.net

[PDF][PDF] Triple combinations in chronic obstructive pulmonary disease--is three better than two?

M Cazzola, MG Matera - Expert Opin. Pharmacother, 2014 - researchgate.net
A growing body of evidence suggests that triple therapy with an antimuscarinic agent, a long-
acting b2-agonist, and an inhaled corticosteroid is efficacious in patients with more severe …